Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 10—October 2013


Antibody Responses against Pneumocystis jirovecii in Health Care Workers Over Time

Serena FongComments to Author , Kieran R. Daly, Renuka Tipirneni, Leah G. Jarlsberg, Kpandja Djawe, Judy V. Koch, Alexandra Swartzman, Brenna Roth, Peter D. Walzer, and Laurence Huang
Author affiliations: San Francisco General Hospital/University of California, San Francisco, San Francisco, California, USA (S. Fong, R. Tipirneni, L.G. Jarlsberg, A. Swartzman, B. Roth, L. Huang); Veterans Affairs Medical Center/University of Cincinnati, Cincinnati, Ohio, USA (K.R. Daly, K. Djawe, J.V. Koch, P.D. Walzer)

Main Article

Table 2

Antibody levels against Msg, San Francisco General Hospital staff, San Francisco, California, USA, 2007–2009*†

Antibody Occupation, estimated geometric mean (95% CI)

p value
Clinical, n = 396 Nonclinical, n = 80
MsgA 12.0 (11.1–12.9) 18.4 (17.1–19.9) 0.45
MsgB 4.9 (4.6–5.1) 6.7 (6.3–7.1) 0.56
MsgC1 38.4 (35.9–41.1) 19.8 (18.6–21.2) 0.004
MsgC3 77.1 (71.9–82.7) 52.9 (49.4–56.8) 0.09
MsgC8 46.0 (42.9–49.2) 27.6 (25.8–29.6) 0.02
MsgC9 34.6 (32.7–36.6) 27.0 (25.5–28.5) 0.17

*Msg, major surface glycoprotein.
†By occupation for all time points and for all participants, adjusted for age and immune disorder,

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO